Showing 301-310 of 1484 results for "".
An Interview With the Inventor of Rinsada
https://modernod.com/podcasts/to-the-point/an-interview-with-the-inventor-of-rinsada/36934/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by retina specialist Srinivas Kondapalli, MD, who developed the Rinsada Irrigating Lid Retractor, which effectively cleanses the conjunctival fornix, palpebral conjunctiva, and bulbar conjunctiva.Astigmatism in CL Wearers • Preservative Exposure
https://modernod.com/podcasts/the-mod-pod/astigmatism-in-cl-wearers-preservative-exposure/36853/Jason E. Compton, OD, FAAO, discusses the importance of managing astigmatism in contact lens wearers (0:58). Selina R. McGee, OD, FAAO, talks about the effects of long-term exposure to preservatives when treating chronic ocular conditions (8:37).Considerations for Use of Two Newly Approved Drugs
https://modernod.com/podcasts/to-the-point/considerations-for-use-of-two-newly-approved-drugs/36928/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.A New Perspective for To the Point
https://modernod.com/podcasts/to-the-point/a-new-perspective-for-to-the-point/36927/This month on To the Point, Jackie Garlich, OD, FAAO, introduces her new co-host, Jessilin Quint, OD, MS, MBA, FAAO. Dr. Quint shares her background and journey in optometry, including how she came to open her dry eye and aesthetics clinic 2 years ago in Maine.An Intro to the Latest Dry Eye Drop
https://modernod.com/podcasts/to-the-point/an-intro-to-the-latest-dry-eye-drop/36925/Get an overview of the recently FDA-approved perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) from Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO. Drs. O’Dell and Garlich discuss the drop’s mechanism of action, dosing regimen, clinical trial findings, side effect profile, and mCL Business Success • Blepharitis and CLs
https://modernod.com/podcasts/the-mod-pod/cl-business-success-blepharitis-and-cls/36845/Check out the newest episode of The MOD Pod to learn strategies for making the most out of your contact lens business from Christopher Lopez, OD (0:46), and how blepharitis interferes with contact lens wear from Ashley O'Dwyer, OD (10:25).Staff Input on Dry Eye Management and Technician Training
https://modernod.com/podcasts/to-the-point/staff-input-on-dry-eye-management-and-technician-training/36916/Jackie Garlich, OD, FAAO, and Leslie O’Dell, OD, FAAO, are joined by Dr. O’Dell’s lead technician, Heather Bollinger. Ms. Bollinger shares questions that have come up while coordinating care for patients with dry eye and imparts her insights on how to effectively train and educate technicians.The Changing Landscape of Optometry in Canada
https://modernod.com/videos/eye-care-insiders/the-changing-landscape-of-optometry-in-canada/37316/Joseph J. Allen, OD, FAAO, Dipl ABO, interviews Harbir Sian, OD, to find out how practicing optometry in Canada differs from practicing in the United States. Dr. Sian discusses the scope of practice, the value of residency, and the different ways to practice in the Great White North.The Makings of a Dry Eye Oasis
https://modernod.com/videos/eye-care-insiders/the-makings-of-a-dry-eye-oasis/37314/In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, talks with Jessilin Quint, OD, MS, MBA, FAAO, about diagnosing and treating dry eye disease, including what tools and treatments to consider bringing into a practice to get started with this specialty.Case Studies in Treating Ocular Surface Disease: Season 5
https://modernod.com/podcasts/the-mod-pod/case-studies-in-treating-ocular-surface-disease-season-5/36830/The newest season includes a new expert panel featuring Jackie Garlich, OD, FAAO; Justin Schweitzer, OD, FAAO; and William B. Trattler, MD, as they share unique cases of meibomian gland dysfunction, neurotrophic keratitis, and the impact of ocular surface disease on cataract surgery planning.